Effects of the muscarinic agonist, 5-methylfurmethiodide, on contraction and electrophysiology of Ascaris suum muscle

International Journal for Parasitology

Volumn 38, Issue 8-9, 2008, Pages 945-957

  Trailovic, Sasa M ^a   Verma, Saurabh ^a   Clark, Cheryl L ^a   Robertson, Alan P ^a   Martin, Richard J ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

4 Aminopyridine; Ascaris suum; Calcium channels levamisole; Electrophysiology; Methylfurmethiodide; Muscarinic receptors; Nicotinic receptors; Potassium channels

Indexed keywords

ACETYLCHOLINE; ATROPINE; CALCIUM CHANNEL; LEVAMISOLE; MECAMYLAMINE; METHYLFURTRETHONIUM; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; POTASSIUM CHANNEL; RINGER SOLUTION;

ANTIBIOTICS; BIOASSAY; CALCIUM; EXPERIMENTAL STUDY; LARVA; MAMMAL; MUSCLE; NEMATODE; ORGANIC NITROGEN COMPOUND; POTASSIUM;

ARTICLE; ASCARIS SUUM; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ELECTROPHYSIOLOGY; MUSCLE CONTRACTION; MUSCLE FIBER MEMBRANE CONDUCTANCE; NONHUMAN; SYNAPTIC TRANSMISSION; VOLTAGE CLAMP;

ANIMALS; ANTHELMINTICS; ASCARIS SUUM; ELECTROPHYSIOLOGY; MUSCARINE; MUSCARINIC AGONISTS; MUSCLE CONTRACTION; PATCH-CLAMP TECHNIQUES;

ASCARIS; ASCARIS SUUM; MAMMALIA;

EID: 43849105103     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2007.11.011     Document Type: Article

References (35)

1. Aceves J., Erlij D., and Martinez-Maranon R. The mechanism of the paralysing action of tetramisole on Ascaris somatic muscle. Br. J. Pharmacol. 38 (1970) 602-607
2. Albert A.P., and Large W.A. Signal transduction pathways and gating mechanisms of native TRP-like cation channels in vascular myocytes. J. Physiol. 570 (2006) 45-51
3. Arevalo J.I., and Saz H.J. Effects of cholinergic agents on the metabolism of choline in muscle from Ascaris suum. J. Parasitol. 78 (1992) 387-392
4. Aubry M.L., Cowell P., Davey M.J., and Shevde S. Aspects of the pharmacology of a new anthelmintic: pyrantel. Br. J. Pharmacol. 38 (1970) 332-344
5. Brading A.F., and Caldwell P.C. The resting membrane potential of the somatic muscle cells of Ascaris lumbricoides. J. Physiol. 217 (1971) 605-624
6. Beech D.J., Muraki K., and Flemming R. Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP. J. Physiol. 559 (2004) 685-706
7. Caulfield M.P., Jones S., Vallis Y., Buckley N.J., Kim G.D., Milligan G., and Brown D.A. Muscarinic M-current inhibition via G alpha q/11 and alpha-adrenoceptor inhibition of Ca2+ current via G alpha o in rat sympathetic neurones. J. Physiol. 477 (1994) 415-422
8. Colquhoun L., Holden-Dye L., and Walker R.J. The Pharmacology of cholinoceptors on the somatic muscle cells of the parasitic nematode Ascaris suum. J. Exp. Biol. 158 (1991) 509-530
9. Dale V.M., and Martin R.J. Oxantel-activated single channel currents in the muscle membrane of Ascaris suum. Parasitology 110 Pt 4 (1995) 437-448
10. Evans A.M., and Martin R.J. Activation and cooperative multi-ion block of single nicotinic-acetylcholine channel currents of Ascaris muscle by the tetrahydropyrimidine anthelmintic, morantel. Br. J. Pharmacol. 118 (1996) 1127-1140
11. Hwang J.M., Chang D.J., Kim U.S., Lee Y.S., Park Y.S., Kaang B.K., and Cho N.J. Cloning and functional characterization of a Caenorhabditis elegans muscarinic acetylcholine receptor. Receptors Channels 6 (1999) 415-424
12. Lee Y.S., Park Y.S., Nam S., Suh S.J., Lee J., Kaang B.K., and Cho N.J. Characterization of GAR-2, a novel G protein-linked acetylcholine receptor from Caenorhabditis elegans. J. Neurochem. 75 (2000) 1800-1809
13. Liu Y., LeBoeuf B., and Garcia L.R. G alpha(q)-coupled muscarinic acetylcholine receptors enhance nicotinic acetylcholine receptor signaling in Caenorhabditis elegans mating behavior. J. Neurosci. 27 (2007) 1411-1421
14. Martin R.J. Electrophysiological effects of piperazine and diethylcarbamazine on Ascaris suum somatic muscle. Br. J. Pharmacol. 77 (1982) 255-265
15. Martin R.J., and Robertson A.P. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57. Parasitology 134 (2007) 1093-1104
16. Martin R.J., Robertson A.P., and Wolstenholme A.J. Mode of action of the macrocyclic lactones. In: Vercruysse J., and Rew R.S. (Eds). Macrocyclic Lactones in Antiparasitic Therapy (2002), CABI, Wallingford 125-140
17. Martin R.J., Thorn P., Gration K.A., and Harrow I.D. Voltage-activated currents in somatic muscle of the nematode parasite Ascaris suum. J. Exp. Biol. 173 (1992) 75-90
18. Martin R.J., and Valkanov M.A. Effects of acetylcholine on a slow voltage-activated non-selective cation current mediated by non-nicotinic receptors on isolated Ascaris muscle bags. Exp. Physiol. 81 (1996) 909-925
19. Melliti K., Meza U., and Adams B.A. RGS2 blocks slow muscarinic inhibition of N-type Ca(2+) channels reconstituted in a human cell line. J. Physiol. 532 (2001) 337-347
20. Newberry N.R., and Priestley T. Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion in vitro. Br. J. Pharmacol. 92 (1987) 817-826
21. Pennington A.J., and Martin R.J. A patch-clamp study of acetylcholine-activated ion channels in Ascaris suum muscle. J. Exp. Biol. 154 (1990) 201-221
22. Purcell J., Robertson A.P., Thompson D.P., and Martin R.J. The time-course of the response to the FMRFamide-related peptide PF4 in Ascaris suum muscle cells indicates direct gating of a chloride ion-channel. Parasitology 124 (2002) 649-656
23. Qian H., Martin R.J., and Robertson A.P. Pharmacology of N-, L-, and B-subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum. FASEB J. 20 (2006) 2606-2608
24. Ramsey I.S., Delling M., and Clapham D.E. An introduction to TRP channels. Annu. Rev. Physiol. 68 (2006) 619-647
25. Roberts K.E., and Newberry N.R. A pharmacological study of the responses induced by muscarinic agonists on the isolated superior cervical ganglion of the guinea-pig. Eur. J. Pharmacol. 186 (1990) 257-265
26. Robertson A.P., Clark C.L., Burns T.A., Thompson D.P., Geary T.G., Trailovic S.M., and Martin R.J. Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle. J. Pharmacol. Exp. Ther. 302 (2002) 853-860
27. Robertson S.J., and Martin R.J. Levamisole-activated single-channel currents from muscle of the nematode parasite Ascaris suum. Br. J. Pharmacol. 108 (1993) 170-178
28. Robertson S.J., Pennington A.J., Evans A.M., and Martin R.J. The action of pyrantel as an agonist and an open channel blocker at acetylcholine receptors in isolated Ascaris suum muscle vesicles. Eur. J. Pharmacol. 271 (1994) 273-282
29. Segerberg M.A., and Stretton A.O. Actions of cholinergic drugs in the nematode Ascaris suum. Complex pharmacology of muscle and motorneurons. J. Gen. Physiol. 101 (1993) 271-296
30. Steger K.A., and Avery L. The GAR-3 muscarinic receptor cooperates with calcium signals to regulate muscle contraction in the Caenorhabditis elegans pharynx. Genetics 167 (2004) 633-643
31. Takai Y., Sugawara R., Ohinata H., and Takai A. Two types of non-selective cation channel opened by muscarinic stimulation with carbachol in bovine ciliary muscle cells. J. Physiol. 559 (2004) 899-922
32. Trailovic S.M., Robertson A.P., Clark C.L., and Martin R.J. Levamisole receptor phosphorylation: effects of kinase antagonists on membrane potential responses in Ascaris suum suggest that CaM kinase and tyrosine kinase regulate sensitivity to levamisole. J. Exp. Biol. 205 (2002) 3979-3988
33. Verma S., Robertson A.P., and Martin R.J. The nematode neuropeptide, AF2 (KHEYLRF-NH(2)), increases voltage-activated calcium currents in Ascaris suum muscle. Br. J. Pharmacol. 151 (2007) 888-899
34. Weisblat D.P., Byerly L., and Russel R.L. Ionic Mechanisms of electrical activity in the somatic muscle cell of the nematode Ascaris lumbricoides. J. Comp. Physiol. 111 (1976) 93-113
35. Zholos A.V., Tsytsyura Y.D., Gordienko D.V., Tsvilovskyy V.V., and Bolton T.B. Phospholipase C, but not InsP3 or DAG, -dependent activation of the muscarinic receptor-operated cation current in guinea-pig ileal smooth muscle cells. Br. J. Pharmacol. 141 (2004) 23-36